News | March 27, 2013

Heart Failure 2013 LA Showcases Heart Disease Startup Technologies

First of kind technologies will be presented

Cardiobridge, VAD, heart pump, hemodynamic support

The Cardiobridge 10 French circulatory support catheter pump expands in the aorta to allows a propeller to increase blood flow in hemodynamically compromised patients.

March 27, 2013 — The Heart Failure 2013 LA meeting will include a showcase of several startup companies offering innovative new approaches to address heart and cardiovascular disease, most of them based in Southern California. The showcase starts at 5:30 p.m. at the event being held Saturday, April 6, at the Millennium Biltmore Hotel in Los Angeles.  

Companies and technologies being highlighted include:

MyoStim Pacers — www.myostimpacers.com — World's first heart failure pacemaker with ability to recruit repairative stem cells to damaged and weakened heart tissue.

Bioheart Inc. — www.bioheartinc.com — Phase III leader in applying adult muscle stem cells to treat advanced heart failure. Only cell type known to grow new contractile muscle in the depths of scar tissue.

BioPace — World's first biological pacemaker made entirely of living cells.

CoroStim — World's first vibrational energy emitting pacemaker that prevents plaque formation in high-risk coronary arteries.

BioLeonhardt — www.bioleonhardt.com — Combination electrical stimulation and multi-stage cell and gene therapy method, composition and devices for treating advanced heart failure. Featuring combined utilization of MicroRNAs, nutrient time release SDF-1, hydrogel, cardiac stem cells, iPS cells and muscle progenitor stem cells. First method under testing with up to 36 repeat injection sessions of stem cells over time via a needle catheter.

Cardiobridge — www.cardiobridge.com — Highest flow rate 10 French circulatory support catheter pump in clinical testing for acute decompensating heart failure and high-risk PCI. Data on about 30 clinical patients will be presented.

AortaCell — Method and device to treat aortic aneurysms noninvasively with an abdominal belt that delivers focal wireless electrical energy to weakened aortic wall that causes repairative autologous stem cells to home to that chosen treatment location.

EndoCell — Method and device for growing new endothelium lining of a damaged artery with a percutaneous needle catheter and endothelial progenitor cells.

MyoValve — Cell seeding method and device for heart valve leaflets invivo or invitro. Designed to reduce risk of calcification and valve replacement.

Valvublator — Percutaneous catheter device for de-calcifying heart valves so a patient may keep their own valve instead of getting an artificial implant.

HeartScore — Composite scoring system of genetic, blood and scan test results (some point of care) that are loaded into the SecondBeat wearable wristwatch for a baseline score. The watch has an infrared sensor that measures real time endothelial health. The baseline score goes up or down if the patient eats well, exercises well and is in compliance with all doctor prescribed medicines and protocols. The composite HeartScore is clearly viewable to patients to help real time guidance of their heart and cardiovascular health.

For more information: www.leonhardtventures.com, www.calxcrowdfund.com, www.laheartfailure.com

 

Related Content

Biotronik Launchs His-Bundle Pacing Tools
News | Pacemakers | June 16, 2020
June 16, 2020 - Biotronik has today announced its commitment to giving physicians additional tools to pace in the His
Videos | Pacemakers | February 13, 2020
This video illustrates how the Micra AV leadless pacemaker is delivered via catheter and enables atrioventricular (AV
The Micra AV leadless pacemaker
News | Pacemakers | February 13, 2020
February 13, 2020 — The U.S.
Results from the MARVEL 2 (Micra Atrial Tracking Using A Ventricular accELerometer) study shows that an investigational set of algorithms in the Medtronic Micra Transcatheter Pacing System (TPS) significantly improves synchrony and cardiac function in patients with atrioventricular (AV) block. This is an impaired electrical conduction between the chambers of the heart.
News | Pacemakers | November 15, 2019
(February 2020 update — the results of this trial led to the FDA clearnace of the Micra AV device in January 2020
Co-principal investigator professor Aydin Babakhani at the UCLA Integrated Sensor Laboratory holds an earlier version of the prototype leadless, wireless amnd batteryless pacemaker. Photo Credit: Cody Duty, Texas Medical Center.

Co-principal investigator professor Aydin Babakhani at the UCLA Integrated Sensor Laboratory holds an earlier version of the prototype leadless, wireless and battery-less pacemaker. Photo Credit: Cody Duty, Texas Medical Center.

News | Pacemakers | November 13, 2019
FDA Warns of Premature Battery Depletion in Some Medtronic Pacemakers
News | Pacemakers | May 07, 2019 | Dave Fornell, Editor
The U.S. Food and Drug Administration (FDA) issued a safety communication to alert healthcare providers and patients...
Artificial Intelligence Can Improve Emergency X-ray Identification of Pacemakers
News | Pacemakers | March 29, 2019
A research team from Imperial College London believes a new software could speed up the diagnosis and treatment of...
Medtronic Recalls Dual Chamber Pacemakers
News | Pacemakers | February 20, 2019
Medtronic is recalling its dual chamber implantable pulse generators (IPGs) due to the possibility of a software error...
CHLA/USC Team Designs Novel Micropacemaker

Model of the human heart with microprocessor located in the pericardial sac and attached to the left ventricle. Graphic courtesy of Business Wire.

News | Pacemakers | June 29, 2018
Investigators at Children's Hospital Los Angeles (CHLA) and the University of Southern California (USC) have...
Permanent Pacing Effective for Older Patients With Syncope and Bifascicular Block
News | Pacemakers | May 24, 2018
Syncope with bifascicular block may be caused by intermittent complete heart block, but competing diagnoses may coexist...